Mucinous ovarian cancer: current therapeutic targets, preclinical progress, and experimental drugs

Autor:	Fabio Barra, Mattia Maramai, Simone Ferrero, Melita Moioli, Mario Valenzano Menada, Valerio Gaetano Vellone, Sergio Costantini
Rok vydání:	2019
Předmět:	0301 basic medicine endocrine system diseases medicine.medical_treatment Drug Evaluation Preclinical Antineoplastic Agents Carcinoma Ovarian Epithelial medicine.disease_cause Targeted therapy 03 medical and health sciences 0302 clinical medicine Drug Development medicine Animals Humans Pharmacology (medical) Epithelial ovarian cancer Molecular Targeted Therapy Cause of death Ovarian Neoplasms Pharmacology business.industry General Medicine medicine.disease Adenocarcinoma Mucinous female genital diseases and pregnancy complications Serous fluid 030104 developmental biology 030220 oncology & carcinogenesis Cancer research Female KRAS Ovarian cancer business Clear cell
Zdroj:	Expert Opinion on Investigational Drugs. 28:1025-1029
ISSN:	1744-7658 1354-3784
DOI:	10.1080/13543784.2019.1693999
Popis:	Among gynecologic malignancies, epithelial ovarian cancer (EOC) is the second most common type and the leading cause of death. The main subtypes (serous, mucinous, endometrioid and clear cell carci...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f998b641508e303b99191840d01590df https://doi.org/10.1080/13543784.2019.1693999 Zobrazit plný text záznamu